Gene Panel Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 18.90 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Gene Panel Market Analysis
The gene panel market studied is anticipated to grow with a CAGR of 18.3%, during the forecast period. The significant factor attributing the market's growth is the rising incidence & prevalence of chronic diseases and increasing technological advancement in diagnostics services and methods. The increasing ongoing research and development in the field of sequencing across the globe also drive the gene panel market. Chronic diseases in developing countries are responsible for more fatalities. Some of the leading chronic diseases in developed countries such as the U.S. are cardiovascular diseases, cancer, diabetes, arthritis, and others. As per the CDC (Centers for Disease Control and Prevention), six in ten adults in the U.S. have a chronic disease. As per the statistics, globally one in three adults has more than two or more chronic diseases, know as multiple chronic conditions. Gene panel diagnostics methods can help in identifying the cause of the disease such as cancer risk assessment and diagnosis of congenital diseases among others. All these key factors are expected to boost the growth of the gene panel market during the forecast period.
Gene Panel Market Trends
This section covers the major market trends shaping the Gene Panel Market according to our research experts:
Test Kits segment is Expected to Hold the Largest Market Share in the Gene Panel Market
- The dominant share is retained by the test kits segment owing to the attributes such as the rising advancement in technology over the last few years, which have opened up many opportunities for growth in the industry. The increase in the prevalence of chronic diseases and the production of tailor-made gene panel test kits for specialized therapeutic areas are aiding the exponential market growth.
- The growing emphasis on governing and raising awareness about these testing by governments in different countries has resulted in the rapid acceptance of these tests worldwide. The rising support for R&D, along with the strong market position of major market players, has created a strong entry channel for new market entrants.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to maintain its supremacy in the overall gene panel market, throughout the forecast period. This is owing to factors such as the rising prevalence of chronic diseases in the region, technological advancement, and the domicile presence of major players in the region driving the growth and responsible for the dominance of the region. The excellently-established biotechnology industry coupled with rising awareness regarding advanced technologies among the population in this region and strong acceptance of developed diagnostics methods is also some of the key factors ensuring the dominance of the region.
Gene Panel Industry Overview
The gene panel market is highly competitive and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making collaborations, acquisition, and launching new products with the other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, QIAGEN, and Integrated DNA Technologies, Inc.
Gene Panel Market Leaders
Illumina, Inc.
Agilent Technologies, Inc.
Thermo Fisher Scientific
QIAGEN
Integrated DNA Technologies, Inc.
*Disclaimer: Major Players sorted in no particular order
Gene Panel Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Prevalance of Chronic Diseases
-
4.2.2 Advantages of Gene Panels
-
-
4.3 Market Restraints
-
4.3.1 High Cost & Genetic Data Security Issue
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Products & Services
-
5.1.1 Test Kits
-
5.1.2 Testing Services
-
-
5.2 By Technique
-
5.2.1 Amplicon Based Approach
-
5.2.2 Hybridization Based Approach
-
-
5.3 By Application
-
5.3.1 Cancer Risk Assessment
-
5.3.2 Pharmacogenetics
-
5.3.3 Diagnosis of Congential Disorders
-
5.3.4 Other Application
-
-
5.4 By End User
-
5.4.1 Hospitals
-
5.4.2 Diagnostic Laboratories
-
5.4.3 Pharmaceutical Companies
-
5.4.4 Others
-
-
5.5 Geography
-
5.5.1 North America
-
5.5.1.1 United States
-
5.5.1.2 Canada
-
5.5.1.3 Mexico
-
-
5.5.2 Europe
-
5.5.2.1 Germany
-
5.5.2.2 United Kingdom
-
5.5.2.3 France
-
5.5.2.4 Italy
-
5.5.2.5 Spain
-
5.5.2.6 Rest of Europe
-
-
5.5.3 Asia-Pacific
-
5.5.3.1 China
-
5.5.3.2 Japan
-
5.5.3.3 India
-
5.5.3.4 Australia
-
5.5.3.5 South Korea
-
5.5.3.6 Rest of Asia-Pacific
-
-
5.5.4 Middle-East and Africa
-
5.5.4.1 GCC
-
5.5.4.2 South Africa
-
5.5.4.3 Rest of Middle-East and Africa
-
-
5.5.5 South America
-
5.5.5.1 Brazil
-
5.5.5.2 Argentina
-
5.5.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Illumina, Inc.
-
6.1.2 Thermo Fisher Scientific
-
6.1.3 Agilent Technologies, Inc.
-
6.1.4 QIAGEN
-
6.1.5 Integrated DNA Technologies, Inc.
-
6.1.6 BGI Group
-
6.1.7 F. Hoffmann-La Roche AG
-
6.1.8 Novogene Corporation
-
6.1.9 GENEWIZ
-
6.1.10 Eurofins Scientific
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Gene Panel Industry Segmentation
A gene panel is a study that analyzes several genes for cancer-related mutations at once. "Gene panels provide common ground among sequencing only one gene like BRCA1 that we are sure is engaged in disease risk and sequencing each gene in the genome.
| By Products & Services | |
| Test Kits | |
| Testing Services |
| By Technique | |
| Amplicon Based Approach | |
| Hybridization Based Approach |
| By Application | |
| Cancer Risk Assessment | |
| Pharmacogenetics | |
| Diagnosis of Congential Disorders | |
| Other Application |
| By End User | |
| Hospitals | |
| Diagnostic Laboratories | |
| Pharmaceutical Companies | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Gene Panel Market Research FAQs
What is the current Gene Panel Market size?
The Gene Panel Market is projected to register a CAGR of 18.90% during the forecast period (2024-2029)
Who are the key players in Gene Panel Market?
Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, QIAGEN and Integrated DNA Technologies, Inc. are the major companies operating in the Gene Panel Market.
Which is the fastest growing region in Gene Panel Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Gene Panel Market?
In 2024, the North America accounts for the largest market share in Gene Panel Market.
What years does this Gene Panel Market cover?
The report covers the Gene Panel Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Gene Panel Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Gene Panel Industry Report
Statistics for the 2023 Gene Panel market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Gene Panel analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
